First DATURA participant enrolled in Ignace Deen Hospital in Guinea

BREAKING NEWS:

The first DATURA participant was enrolled in Ignace Deen Hospital, Conakry, Guinea on April 21^st 2022. It is a 25-years old woman who just discovered her HIV status with CD4 count of 67 cells/µL. She has been enrolled in DATURA with a positive sputum Xpert MTB/RIF, a positive urine LAM test and a chest X-ray highly suggestive of tuberculosis.

Congratulations to the whole Guinea team for this major achievement!

DATURA – a clinical trial

DATURA addresses people who are co-infected with TB and HIV. It is a research project that aims to assess whether an intensified initial TB treatment could increase survival in hospitalised, HIV-infected adults and adolescents compared to the standard TB treatment regime.

DATURA is registered in ClinicalTrials.gov : NCT04738812

Important DATURA dates:

Mozambique participated as a trial site by 2024, with first patient inclusion in February 15th, 2024
The European and Developing Countries Clinical Trials Partnership (EDCTP)signed the Grant 14 April 2020.
Official starting date of the project period is 1 May 2020. The project will last for 54 months from this date.
DATURA kick-off 14-15 Sept. 2020
First participant enrolled on April 21^st, 2022.
All African sites recruiting by August 2022.
EDCTP grant extended for an additional 14 months until December 2025.